Myotonic Dystrophy Type I: Metformin Study

We are investigating whether metformin can improve muscle and overall function in patients with Myotonic Dystrophy Type I. The study will also assess the safety of metformin and its effects on quality of life.

>2 years 6-10 visits Confirmation phase (III)Cost Reimbursement Partially Remote Standard Medicines OralNeurologyOrthopedics and Traumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Metformine Viatris

Metformine Viatris is a medicine used to lower blood sugar in people with type 2 diabetes.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Metformin Hydrochloride

Metformin hydrochloride is a substance that helps lower blood sugar in people with type 2 diabetes.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abmetfina Xr

Adimet

Adimet Xr

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Centre Hospitalier Universitaire D'Angers

Centre de Référence des Maladies Neuromusculaires

Angers, France

Centre Hospitalier Universitaire De Toulouse

Centre de Référence des Maladies Neuromusculaires

Blagnac, France

Centre Hospitalier Universitaire De Bordeaux

Centre de Référence des Maladies Neuromusculaires

Bordeaux, France

Sponsor: Assistance Publique Hopitaux De Paris

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.